Market Research Report on Digbi Health

Company Overview

Name:

Digbi Health

Mission:

Digbi Health aims to make chronic illness optional by utilizing Precision Biology to treat conditions such as obesity, cardiometabolic issues, and digestive health.

Founding:

No information is available regarding the specific date of founding or the founders.

Key People:

• Ranjan Sinha - Founder and CEO

• Dr. Daniel Almonacid - Chief Scientific Officer

• Alec Thompson - Regional Head of Sales

• Aniiket Sengar - Director of Marketing Operations

• Santosh Saravanan - Director of Product and Engineering

• Board of Directors includes notable names such as Mark Ganz, Radhika Anant, Salo Sredni, Ashok Belani, and Board Advisors John Morgan, Steve Blumenfield.

Headquarters:

800 El Camino Real West Suite 180, Mountain View, CA, United States, 94040

Number of Employees:

No information is available.

Revenue:

No information is available.

What is the company known for:

Digbi Health is renowned for its Precision Biology platform that integrates gut microbiome, CGM, and genetics to holistically prevent and treat obesity, cardiometabolic, and digestive conditions.

Products

What Products They Offer:

1. Digbi Cares

• Designed for individuals with prediabetes, T2D, PCOS, hypertension, GI issues & obesity.

• Key Features:

• At-home gut biome and genetic test.

• Insulin levels measured through Continuous Glucose Monitoring.

• Health coaching and meal analysis tailored to biology.

• 12-month chat access to nutritionists and care teams.

• Self-help educational content and food guides.

2. GLP-Fit

• A medically managed intervention using anti-obesity medications.

• Key Features:

• Includes all features of Digbi Cares.

• Anti-obesity medication management using a proprietary AI engine.

• Consultations with MDs and tapering off weight management drugs.

• Targeted for medium to high symptom severity.

Recent Developments

Recent Developments in the Company:

1. Equity Crowdfunding Offering (September 2024):

• Digbi Health launched an SEC-regulated offering to democratize investment opportunities and make Precision Biology-based care accessible to millions.

2. Partnerships:

• Partnered with a leading public health insurance trust to manage GLP-1 drug costs through Obesity Compass.

3. Programs:

• Launched GLP-Fit™ to streamline GLP-1 drug management and provide precise obesity care.

New Features & Products Launched:

• GLP-Fit™ Program:

• Utilizes precision biology for obesity treatment with an 87% accuracy rate.

New Partnerships:

• Collaborated with Gulf Coast Regional Blood Center to enhance employee health programs.

• Explored obesity risk tests in partnership with Novo Nordisk through a pilot project.

• Expanded access to its platform through partnerships like the one with Virgin Pulse to address digestive health as part of a curated ecosystem.

This report encapsulates the key aspects of Digbi Health as garnered from the available data, showcasing its innovative approach in the healthcare sector focused on precision medicine and personalized care.